Evidence map›Paper›PMID 34079634›Full record

ArticleAmerican journal of blood research2021

Hospital acquired infection in a department of hematology-oncology care in the Congo.

Lydie Ocini Ngolet, Alexis Fortuné Bolenga Liboko, Bienvenu Roland Ossibi Ibara, Alexis Elira Dokekias

Open access · greenAbstract read
In one paragraph

Article in American journal of blood research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lydie Ocini NgoletDepartment of Hematology, Teaching Hospital 13 Auxence Ikonga Avenue, P.O Box 32, Brazzaville, Congo.
Alexis Fortuné Bolenga LibokoDepartment of Oncology, Teaching Hospital 13 Auxence Ikonga Avenue, P.O Box 32, Brazzaville, Congo.
Bienvenu Roland Ossibi IbaraDepartment of Infectious Diseases, Teaching Hospital 13 Auxence Ikonga Avenue, P.O Box 32, Brazzaville, Congo.
Alexis Elira DokekiasDepartment of Hematology, Teaching Hospital 13 Auxence Ikonga Avenue, P.O Box 32, Brazzaville, Congo.
Centre Hospitalier et Universitaire de Brazzaville · CG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesHospital Acquired Infection (HAI) is a major cause of morbidity and mortality in hemato-oncology. The study aims to report the incidence of hospital-acquired infections in patients with hematological malignancies and the risk factors associated with them. MATERIAL AND

methodsAn observational study with cross-sectional data collection was carried out from January 1, 2019, to April 30, 2020, in the department of hematology of Brazzaville University Hospital. The study concerned 77 patients diagnosed with hematological malignancies admitted for a course of chemotherapy. Written consent was obtained from each participant. Participants were divided into two groups: with HAI (n=50) and without HAI (n=27). They were compared using the chi-square test and Student's T-test. Univariate and multivariate analyses of the association of HAI with all the risk factors were performed for analysis of the 2 x k contingency tables and repeated using logistic regression.

resultsThe cumulative incidence was 64.9% with a 95% confidence interval of [53.8-74.7]. The time to onset of HAIs was 10.6±6.50 days. The incidence of HAI was significantly greater in acute myelogenous leukemia (80%), grade 4 neutropenia (80%). The risk factors were hospitalization stay of over 14 days (OR: 1.09), the regimen: daunorubicin-aracytine (OR: 5.96), the hemoglobin level on admission (OR: 0.72), and the neutropenia of grade 4 (OR: 7.9). The most common clinically identified focus of infection was peripheral venous infections. The fatality rate was 10%.

conclusionThe determination of HAI and the identification of its risk factors make it possible to establish prevention strategies.

Indexed as

BrazzavillecancerHospital-acquired infections

Identifiers

PMID34079634
PMCPMC8165720
OpenAlexW3164699741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.